Sorrento Therapeutics Inc
LSE:0L85

Watchlist Manager
Sorrento Therapeutics Inc Logo
Sorrento Therapeutics Inc
LSE:0L85
Watchlist
Price: 0.015 USD -38.02% Market Closed
Market Cap: 1.7m USD

Wall Street
Price Targets

0L85 Price Targets Summary
Sorrento Therapeutics Inc

There are no price targets for 0L85.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Sorrento Therapeutics Inc Competitors:
Price Targets
NVAX
Novavax Inc
63% Upside
XGN
Exagen Inc
195% Upside
PHM
Pharma Mar SA
21% Upside
688428
InnoCare Pharma Ltd
80% Upside
OCGN
Ocugen Inc
431% Upside
IMTX
Immatics NV
95% Upside
CHRS
Coherus BioSciences Inc
261% Upside
ALKS
Alkermes Plc
46% Upside

Revenue
Forecast

Revenue Estimate
Sorrento Therapeutics Inc

For the last 11 years the compound annual growth rate for Sorrento Therapeutics Inc's revenue is 55%. The projected CAGR for the next 3 years is 88%.

55%
Past Growth
88%
Estimated Growth
Estimates Accuracy
0%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sorrento Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
6%
Average Beat

Net Income
Forecast

Net Income Estimate
Sorrento Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-85%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 0L85's stock price target?
Not Available

0L85 doesn't have any price targets made by Wall Street professionals.

What is Sorrento Therapeutics Inc's Revenue forecast?
Projected CAGR
88%

For the last 11 years the compound annual growth rate for Sorrento Therapeutics Inc's revenue is 55%. The projected CAGR for the next 3 years is 88%.

Back to Top